D.E. Shaw & Co’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-282,154
| Closed | -$10.8M | – | 3395 |
|
|
2023
Q2 | $10.8M | Sell |
282,154
-37,552
| -12% | -$1.44M | 0.01% | 836 |
|
|
2023
Q1 | $7.4M | Sell |
319,706
-40,079
| -11% | -$928K | 0.01% | 1114 |
|
|
2022
Q4 | $9.43M | Sell |
359,785
-119,742
| -25% | -$3.14M | 0.01% | 1016 |
|
|
2022
Q3 | $9.43M | Buy |
479,527
+225,945
| +89% | +$4.44M | 0.01% | 943 |
|
|
2022
Q2 | $4.44M | Buy |
253,582
+191,135
| +306% | +$3.34M | 0.01% | 1667 |
|
|
2022
Q1 | $1.02M | Sell |
62,447
-65,655
| -51% | -$1.07M | ﹤0.01% | 2863 |
|
|
2021
Q4 | $2.09M | Buy |
128,102
+95,966
| +299% | +$1.56M | ﹤0.01% | 2341 |
|
|
2021
Q3 | $410K | Buy |
+32,136
| New | +$410K | ﹤0.01% | 2926 |
|
|
2021
Q1 | – | Sell |
-35,736
| Closed | -$567K | – | 3257 |
|
|
2020
Q4 | $567K | Buy |
35,736
+30,054
| +529% | +$477K | ﹤0.01% | 2241 |
|
|
2020
Q3 | $69K | Sell |
5,682
-16,533
| -74% | -$201K | ﹤0.01% | 2508 |
|
|
2020
Q2 | $257K | Sell |
22,215
-2,883
| -11% | -$33.4K | ﹤0.01% | 2378 |
|
|
2020
Q1 | $343K | Sell |
25,098
-56,805
| -69% | -$776K | ﹤0.01% | 2286 |
|
|
2019
Q4 | $484K | Buy |
81,903
+43,266
| +112% | +$256K | ﹤0.01% | 2206 |
|
|
2019
Q3 | $204K | Buy |
+38,637
| New | +$204K | ﹤0.01% | 2395 |
|
|
2019
Q2 | – | Sell |
-17,407
| Closed | -$346K | – | 2791 |
|
|
2019
Q1 | $346K | Buy |
17,407
+9,330
| +116% | +$185K | ﹤0.01% | 2218 |
|
|
2018
Q4 | $107K | Buy |
+8,077
| New | +$107K | ﹤0.01% | 2455 |
|
|
2016
Q1 | – | Sell |
-3,890
| Closed | -$547K | – | 2771 |
|
|
2015
Q4 | $547K | Buy |
+3,890
| New | +$547K | ﹤0.01% | 2035 |
|